vimarsana.com
  1. Home
  2. Live Updates
  3. Molly Macleod - Breaking News

Latest Breaking News On - Molly macleod - Page 1 : vimarsana.com

Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting

CAMBRIDGE, Mass. (BUSINESS WIRE) Jun 3, 2024

Dana farber cancer instituteUnited statesUnited kingdomRushmie nofsingerMolly macleodJay backstromToni choueiriGenitourinary gu oncology at dana farber cancer instituteLank centerScholar rock incExchange commissionAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingChief executive officer

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMolly macleodRushmie nofsingerExchange commissionScholar rock incEquity planScholar rockNasdaq listing ruleSecurities act

Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani

CAMBRIDGE, Mass. (BUSINESS WIRE) Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm.

United statesUnited kingdomAdicet bioJay backstromMo qatananiAmir nashatMolly macleodSynageva biopharmaRushmie nofsingerDavid hallalBaylor college of medicineInstitute for diabetesUniversity of californiaUniversity of pennsylvania school medicineExchange commissionCalifornia life sciences

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass. (BUSINESS WIRE) Nov 17, 2023

United statesUnited kingdomRushmie nofsingerMolly macleodScholar rock incExchange commissionEquity planScholar rockNasdaq listing ruleStock option awardSecurities actBusiness wire

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diego convention centerUnited statesSan diegoUnited kingdomJay backstromRushmie nofsingerTimothy yapSusan henryMolly macleodExchange commissionScholar rock incUniversity of texas md anderson cancer centerSociety for immunotherapy of cancerTranslational sciencesDepartment of investigational cancer therapeuticsAnnual meeting
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.